This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Some key public health figures are taking an extraordinary step to try to shore up U.S. vaccination policy, feared to be under threat from Health and Human Services Secretary Robert F. Kennedy Jr., a longtime vaccine critic. The “Vaccine Integrity Project,” which was publicly launched Thursday by the University of Minnesota’s Center for Infectious Disease Research and Policy, will be aimed at assessing the best ways for vaccine proponents to safeguard vaccination policy and
Morepen Laboratories has announced the launch of four new productsTicapen, UdoFix, LycoMore, and Acifix Raftin April 2025 for the Indian market. This follows the introduction of Empamore last month, furthering the companys stated goal to offer research-led pharmaceutical products across key therapeutic areas. These launches form part of Morepens broader strategy to enhance its finished dosages segment while leveraging its internal research and development (R&D) capabilities.
The federal health department is not creating a new registry of Americans with autism, a Department of Health and Human Services official said in a written statement Thursday. Instead, the official said, HHS will launch a $50 million research effort to understand the causes of autism spectrum disorder and improve treatments. The announcement arrives two days after National Institutes of Health Director Jay Bhattacharya announced the intent to create such a registry at an all staff meeting, kicki
Lupin has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Tolvaptan Tablets in strengths of 15 mg, 30 mg, 45 mg, 60 mg, and 90 mg. The approved product is bioequivalent to Jynarque Tablets of the same strengths, originally developed by Otsuka Pharmaceutical Company Lupin is the exclusive first-to-file applicant for this product, making it eligible for 180 days of generic drug exclusivity in the United States.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
The debate over the future of Medicaid continues to rage among Republicans. A House budget proposal released in February would slash up to $880 billion in spending over the next decade from the public health insurance program that 80 million low-income Americans rely on — including children, seniors, and people with disabilities.
The government has launched a call for evidence to support its Mens Health Strategy, which was announced last year and is the first of its kind. Health professionals are among those being asked for ideas and evidence to the unique challenges men face throughout their lives. The strategyis being developed to tackle stark inequalities in […] The post Government seeks pharmacists' views to underpin first-ever mens health strategy appeared first on The Pharmacist.
NASHVILLE, Tenn. — Robert F. Kennedy Jr.’s appearance at a major addiction and drug policy conference was marked by repeated interruptions on Thursday, as protesters and jeers forced him to pause and wait for noise to subside at least five times during his 36-minute speech. A packed and deeply divided audience at the Rx and Illicit Drug Summit, taking place at a conference center on the city’s outskirts, applauded the health secretary as he entered and exited the stage
284
284
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
NASHVILLE, Tenn. — Robert F. Kennedy Jr.’s appearance at a major addiction and drug policy conference was marked by repeated interruptions on Thursday, as protesters and jeers forced him to pause and wait for noise to subside at least five times during his 36-minute speech. A packed and deeply divided audience at the Rx and Illicit Drug Summit, taking place at a conference center on the city’s outskirts, applauded the health secretary as he entered and exited the stage
A new AI-based company launched by the prolific venture capital firm Flagship Pioneering marks another platform approach in forward-thinking early science.
This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. I think I’ll go for a walk outside now The XBI is callin’ my name (I hear ya now) I just can’t stay uninvested all day I gotta get out get some of those bio-rays Biotechs are smilin’ Sunshine day Biotechs are laughin’ Sunshine day Every biotech seems so happy today It’
The initiative was formalised in the presence of Dr Rajesh Gokhale, Secretary of the Department of Biotechnology (DBT). These Centres will work across rare diseases, cancer, and infectious disease surveillance. The objective is to align with Indias public health strategies and national genomic ambitions. The CoEs are expected to also act as platforms for education and skill development in sequencing technologies.
How did Ireland become a hotspot for pharmaceutical manufacturing? What are the products that will come out of Flagship’s latest startup centered around “preemptive medicine”? And who among the co-hosts is the best singer? We discuss all that and more on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Avery Dennison Corporation, a global company in materials science and digital identification, has announced the opening of its first radio-frequency identification (RFID) inlays and labels manufacturing facility in India. The facility, located in Pune, will officially open on 23 April 2025. This move forms part of the companys long-term commitment to supporting the growth of RFID technology in South Asia under the Government of Indias Make in India initiative.
Caribou Biosciences is delaying the readout of clinical trials involving its CRISPR T-cell therapies for blood cancer — hoping that longer follow-up will deliver enough positive data to keep the programs and the struggling biotech company alive. The company’s decision, announced Thursday, amounts to an all-or-nothing bet on the viability of two off-the-shelf CAR-T therapies that have, so far, failed to meet the high expectations set when Caribou emerged from the lab of CRISPR
Introduction Artificial Intelligence (AI) is no longer just a futuristic concept in pharmaceutical marketingits the present and future. In 2025, AI-powered pharma marketing is transforming how companies engage healthcare professionals (HCPs), patients, and stakeholders. With evolving compliance requirements and rising demand for personalization, pharma marketers are adopting intelligent platforms to stay ahead.
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Happy Thursday. I saw Lucy Dacus perform last night. What an evening!
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
This recommendation facilitates treating the activated phosphoinositide 3-kinase delta (PI3K) syndrome (APDS) in patients aged 12 years and above. The oral therapy is now accessible and funded in England through the Innovative Medicines Fund and is expected to be funded in Wales within the coming three months. The NICE endorsement is supported by the comprehensive data, including a Phase III clinical trial of leniolisib, which showed significant improvements in immune deficiency and dysregulatio
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We’ve got a busy earnings day today, so let’s get straight into it.
"Warning: Are You About to Fall into the Generic Drug Development Trap? As a seasoned pharma professional, I've seen it time and time again: promising generic drug candidates that fail to deliver due to avoidable pitfalls. Don't let this happen to you. Check out our latest blog post to learn how to avoid the most common mistakes in generic drug development: [link] From patent strategies to regulatory hurdles, we break down the key takeaways to help you navigate the complex landscape of gene
ViroCell Biologics has manufactured a GMP-grade lentiviral vector for a University College London (UCL) clinical trial aimed at tackling relapse in paediatric acute lymphoblastic leukaemia (ALL), a common childhood cancer. Led by professor Persis Amrolia, a pioneer in CAR T-cell therapy at UCL and Great Ormond Street Hospital (GOSH), the trial intends to improve outcomes […] The post ViroCell and UCL launch trial to treat childhood leukaemia relapse appeared first on Pharmafile.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
The charge for prescriptions in England will remain at 9.90 for May 2025, as government considerations about a price increase have not yet concluded, Community Pharmacy England (CPE) has said. The cost of prescription Pre-Payment Certificates (PPCs), including HRT PPCs, will also remain unchanged for May. The pharmacy negotiator said that it would 'update community […] The post Prescription charge to stay at 9.90 for May appeared first on The Pharmacist.
The US Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) to EvoLiver, Mursla Bios surveillance platform for hepatocellular carcinoma (HCC), a common form of liver disease. With its support, Mursla hopes to improve the effectiveness of early liver cancer detection. The FDAs BDD bolsters market access and commercial adoption by accelerating the […] The post Mursla Bios platform for surveillance of liver cancer receives FDA approval appeared first on Pharmaf
The National Pharmacy Association (NPA) will not be recommending co-ordinated protest action to its members, it has announced. But it said thatindividual pharmacies might still have to take steps such as reducing services in order to save costs. NPA chair Nick Kaye said that 'despite much needed additional investment, pharmacies will face a substantial gap […] The post BREAKING: NPA 'decides against' collective action appeared first on The Pharmacist.
Swedish biopharma company, Hansa Biopharma, has announced the appointment of new chief executive officer (CEO) Rene Aguiar-Lucander, replacing Sren Tulstrup who led the company for seven years. Aguiar-Lucander has a wealth of experience in senior leadership positions in other biopharma companies, playing key roles in the growth and development of companies.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Researchers have suggested a potential approach to measure the effective work of powder adhesion between particle-surface contact, using the drop test method. Specifically, they assessed irregularly shaped ibuprofen powders and spherical aluminium-alloy powders.Citing current adhesion challenges during tablet manufacturing, the authors highlighted the need to numerically predict if a new formulation may exhibit adhesion problems earlier [in R&D].
Neurizon Therapeutics, a clinical-stage biotech company focusing on treatments for neurodegenerative diseases, has announced three leadership appointments. These will support the companys ambition to commercialise its leading therapy NUZ-001, a treatment for Amyotrophic lateral sclerosis (ALS) motor neurone disease. Kathryn Williams joins as chief regulatory officer (CRO).
At Pharmacy Mentor, we speak with pharmacists every day. That means we have a unique window into their needs. One question we hear again and again is how can pharmacists better use social media to drive business. Pharmacists know that their customers are on places like Instagram and TikTok , but they are not always sure how to reach these people. The problems were time and budget.
The drugmaker absorbed additional tariff-related costs in the first quarter, but has taken steps to lower the financial impact it’ll have for the rest of the year and beyond.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
After a blockbuster inaugural event and tremendous feedback from attendees, were excited to announce that the Drug Channels Leadership Forum (DCLF) returns on March 1618, 2026 , at the Turnberry Resort & Spa in Miami. This one-of-a-kind, off-the-record event convenes senior leaders across the drug channel to address todays most pressing industry issues.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
324 
Let's personalize your content